Armata Pharmaceuticals, Inc. (ARMP) Misses Q1 EPS by 4c

Armata Pharmaceuticals, Inc. (NYSE: ARMP) reported Q1 EPS of ($0.20), $0.04 worse than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Armata Pharmaceuticals, Inc. (ARMP) click here.

You May Also Be Interested In

• Intuit (INTU) Tops Q4 EPS; Offers FY27 Guidance
• Morgan Stanley Double Downgrades Gujarat Energy (GUJENERG:IN) to Underweight
• Truecaller AB (TRUEB:SS) PT Raised to SEK46 at JPMorgan